Form 8-K - Current report:
SEC Accession No. 0000950170-22-010981
Filing Date
2022-06-01
Accepted
2022-06-01 07:08:01
Documents
19
Period of Report
2022-06-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clnn-20220601.htm   iXBRL 8-K 72025
2 EX-99.1 clnn-ex99_1.htm EX-99.1 2615
3 EX-99.2 clnn-ex99_2.htm EX-99.2 2793
4 EX-99.3 clnn-ex99_3.htm EX-99.3 2946
5 GRAPHIC clnn-ex99_1s1.jpg GRAPHIC 251806
6 GRAPHIC clnn-ex99_2s1.jpg GRAPHIC 236095
7 GRAPHIC clnn-ex99_3s1.jpg GRAPHIC 233697
  Complete submission text file 0000950170-22-010981.txt   1307563

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clnn-20220601_def.xml EX-101.DEF 28274
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clnn-20220601.xsd EX-101.SCH 3328
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clnn-20220601_pre.xml EX-101.PRE 29430
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clnn-20220601_lab.xml EX-101.LAB 36057
13 EXTRACTED XBRL INSTANCE DOCUMENT clnn-20220601_htm.xml XML 6627
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 22985948
SIC: 2834 Pharmaceutical Preparations